About Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation is a company based in Alachua (United States) founded in 1999 was acquired by Syncona in October 2022.. Applied Genetics Technologies Corporation has raised $98.85 million across 10 funding rounds from investors including Syncona, HHS and Alta Partners. The company has 83 employees as of June 30, 2021. Applied Genetics Technologies Corporation offers products and services including AAV Gene Therapy. Applied Genetics Technologies Corporation operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Alachua, United States
- Employees 83 as on 30 Jun, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Applied Genetic Technologies Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation offers a comprehensive portfolio of products and services, including AAV Gene Therapy. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers functional genes to treat genetic retinal diseases effectively.
Unlock access to complete
Unlock access to complete
Funding Insights of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation has successfully raised a total of $98.85M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $444.06 thousand completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Grant — $444,061
-
First Round
First Round
(01 Dec 2003)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2013 | Amount | Grant - Applied Genetics Technologies Corporation | Valuation |
investors |
|
| Nov, 2012 | Amount | Series B - Applied Genetics Technologies Corporation | Valuation | Alta Partners , SR One | |
| May, 2012 | Amount | Series B - Applied Genetics Technologies Corporation | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Syncona, HHS and Alta Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location | |
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Applied Genetics Technologies Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Applied Genetics Technologies Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Applied Genetics Technologies Corporation Comparisons
Competitors of Applied Genetics Technologies Corporation
Applied Genetics Technologies Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Applied Genetics Technologies Corporation
Frequently Asked Questions about Applied Genetics Technologies Corporation
When was Applied Genetics Technologies Corporation founded?
Applied Genetics Technologies Corporation was founded in 1999 and raised its 1st funding round 4 years after it was founded.
Where is Applied Genetics Technologies Corporation located?
Applied Genetics Technologies Corporation is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
Is Applied Genetics Technologies Corporation a funded company?
Applied Genetics Technologies Corporation is a funded company, having raised a total of $98.85M across 10 funding rounds to date. The company's 1st funding round was a Series B of $750K, raised on Dec 01, 2003.
How many employees does Applied Genetics Technologies Corporation have?
As of Jun 30, 2021, the latest employee count at Applied Genetics Technologies Corporation is 83.
What does Applied Genetics Technologies Corporation do?
Applied Genetics Technologies Corporation was founded in 1999 in Alachua, United States, within the biotechnology sector. Focus is placed on developing gene therapies for rare ophthalmologic conditions caused by genetic mutations, including lead programs in Achromatopsia, X-Linked Retinoschisis, and X-Linked Retinitis Pigmentosa. An adeno-associated virus-based delivery system is employed for these therapies, targeting orphan diseases in ophthalmology. Operations center on advancing clinical-stage gene therapy solutions.
Who are the top competitors of Applied Genetics Technologies Corporation?
Applied Genetics Technologies Corporation's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Applied Genetics Technologies Corporation offer?
Applied Genetics Technologies Corporation offers AAV Gene Therapy.
Who are Applied Genetics Technologies Corporation's investors?
Applied Genetics Technologies Corporation has 9 investors. Key investors include Syncona, HHS, Alta Partners, InterWest, and Intersouth Partners.